##  [Partnering opportunities - Out licensing and divestments](/node/665681 "Partnering opportunities - Out licensing and divestments") 

  



 Out licensing and divestments



  

Novartis is open to discussing the divestment of certain commercial products in different regions, as well as granting licenses to development-stage compounds that have been de-prioritized due to strategic reasons.

 ![Sven Werner](/sites/novartis_com/files/styles/crop_freeform/public/2024-01/sven-werner.jpg.webp?itok=7LUift47 "Sven Werner")

 



### Out licensing

#### Sven Werner

[Contact](https://novartis.partneringplace.com/SubmissionUI/novartis/submission)







 ![Person icon](/sites/novartis_com/files/styles/crop_freeform/public/2025-10/person-icon.png.webp?itok=jjbTirKt "Person icon")

 



### Divestments

#### Jean Marc Séquier

[Contact](https://novartis.partneringplace.com/SubmissionUI/novartis/submission)









 

 

 



 



 

 





 



- [Print](/node/665681/printable/print)
- [PDF](/node/665681/printable/pdf)